Compare LEU & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LEU | PLSE |
|---|---|---|
| Founded | 1998 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.6B |
| IPO Year | 1998 | 2015 |
| Metric | LEU | PLSE |
|---|---|---|
| Price | $182.72 | $52.96 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 1 |
| Target Price | ★ $255.55 | $22.00 |
| AVG Volume (30 Days) | ★ 545.1K | 531.6K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.21 | N/A |
| Revenue | ★ $193,000,000.00 | N/A |
| Revenue This Year | $3.76 | $840.00 |
| Revenue Next Year | $6.04 | $287.54 |
| P/E Ratio | $149.51 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $142.13 | $12.56 |
| 52 Week High | $464.00 | $58.90 |
| Indicator | LEU | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 52.41 | 67.27 |
| Support Level | $164.04 | $24.27 |
| Resistance Level | $201.36 | N/A |
| Average True Range (ATR) | 12.00 | 3.51 |
| MACD | -0.50 | -0.20 |
| Stochastic Oscillator | 44.38 | 64.41 |
Centrus Energy Corp is engaged in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment has two components which include the sale of separative work units and uranium. The Technical Solutions segment provides engineering, design, and manufacturing services to government and private sector customers. The majority of the firm's revenue is derived from the LEU segment. It has a business presence in the U.S. and other countries, of which prime revenue is generated in the U.S.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.